EU Proposes Changes To Labeling Of Investigational Drugs Under Clinical Trial Regulation
Executive Summary
The European Commission is inviting stakeholder feedback on proposals to do away with the need to display the expiry date on the primary packaging of investigational drugs in certain situations.